EisnerAmper Podcast
EisnerAmper podcasts are a great way for busy, on-the-go professionals to learn the ins and outs of timely business topics that matter: new tax regulations, cybersecurity, wealth management, capital investment and more. At home or at work, or during the commute or working out, EisnerAmper podcasts help you get down to business.
Episodes
Wednesday Jul 17, 2024
PE Dealbook: Private Equity Dealmaking Outlook for the Remainder of 2024
Wednesday Jul 17, 2024
Wednesday Jul 17, 2024
In this episode of EisnerAmper's Private Equity Dealbook, Elana Margulies-Snyderman, Director, Publications, EisnerAmper, speaks with Michael Petrizzo, Partner, Saul Ewing. Michael shares his thoughts on dealmaking, including how the climate has impacted transactions, best practices for companies contemplating buy-side and sell-side transactions, considerations on executing a Letter of Intent, the due diligence process for M&A activity and more.
Tuesday Jul 16, 2024
Working With the Right Surety Agent to Build Your Bonding Capacity: Episode 1
Tuesday Jul 16, 2024
Tuesday Jul 16, 2024
In episode one of this four-part podcast series, Don Hoffman, EisnerAmper Partner and National Construction Leader, speaks with Brian Whipple, National Surety Practice Leader at Risk Strategies, about the history of bonding, the difference between surety bonds and insurance, the rights under a surety bond, and questions to ask when looking for a surety agent.
Friday Jul 12, 2024
Breaking Ground: The ROI of Healthy Buildings
Friday Jul 12, 2024
Friday Jul 12, 2024
In this episode of Breaking Ground, EisnerAmper's podcast delving into the future of real estate, host Sarah Brand sits down with the Founder and CEO of Motko. They dive into the growing trend of wellness-focused buildings and how Class B and C properties can be transformed into competitive assets. Listen in to discover the potential financial returns, health benefits, and certifications associated with creating a healthier built environment.
Thursday Jul 11, 2024
Engaging Alternatives: Outlook for Corporate Credit and Special Situations Investing
Thursday Jul 11, 2024
Thursday Jul 11, 2024
In this episode of Engaging Alternatives Spotlight, Elana Margulies-Snyderman, Director, Publications, EisnerAmper, speaks with Loren Remetta, CIO, Bow Bridge, a corporate credit and special situations manager. Loren shares his outlook for high-yield and credit derivative markets and more.
Tuesday Jul 09, 2024
TechTalk: To the Moon! Startup Launches New Era of Data Storage
Tuesday Jul 09, 2024
Tuesday Jul 09, 2024
Chris Stott, Founder, Chair, CEO of Lonestar, talks with EisnerAmper's TechTalk host Fritz Spencer about pioneering the future of data services on the Moon in the pursuit of solving customer demands. In this episode, Chris shares the excitement around Lonestar’s first successful lunar mission in February 2024 and what it means to launch the first data center beyond Earth’s orbit—advancing the vision for a greater lunar technology ecosystem.
Tuesday Jun 25, 2024
Tuesday Jun 25, 2024
Alex Lassiter, Founder and CEO of Greenplaces, talks with EisnerAmper's TechTalk host Janina Teoxon about how his startup is empowering business leaders across industries to achieve their sustainability goals. In this episode, Alex describes his all-in-one sustainability platform as a “chief sustainability officer in a box,” making the process to measure, report, and reduce carbon emissions more accessible to non-Fortune 500 companies. Note: The environmental, social and governance (“ESG”) platform provides a dashboard on how to both reduce your footprint and save money. Learn how Greenplaces is meeting the evolving needs of businesses—and the planet.
Thursday Jun 20, 2024
Thursday Jun 20, 2024
In this episode of Engaging Alternatives Spotlight, Elana Margulies-Snyderman, Director, Publications, EisnerAmper, speaks with Daniel Frankenstein, Co-Founder of Joule Ventures, a U.S.-based partner-only seed fund investing in Israel’s most compelling enterprise-focused entrepreneurs. Daniel shares his outlook for investing in these entrepreneurs including the greatest opportunities, challenges and more.
Thursday Jun 13, 2024
Engaging Alternatives: Private Equity Seeding/Investing in Emerging Managers
Thursday Jun 13, 2024
Thursday Jun 13, 2024
In this episode of Engaging Alternatives Spotlight, Elana Margulies-Snyderman, Director, Publications, EisnerAmper, speaks with Dan Pogue and Peter Birk, Vice Presidents of Moelis Asset Management’s Catalyst Partners, which provides strategic capital to private equity emerging managers. The duo share their outlook for seeding private equity managers, including the greatest opportunities and challenges, how the firm integrates ESG, DEI and more.
Wednesday Jun 12, 2024
PE Dealbook: Private Equity Dealmaking in the Hospitality Sector
Wednesday Jun 12, 2024
Wednesday Jun 12, 2024
In this episode of Private Equity Dealbook, Elana Margulies-Snyderman, Director, Publications, EisnerAmper, speaks with Mark Leavitt, Co-Founder and Managing Partner, Enlightened Hospitality Investments, a growth equity fund he runs with restauranteur Danny Meyer that invests in the hospitality sector. Mark discusses some of the transactions he has completed, including Culture Pop and Goldbelly. He walks us through the processes, along with the opportunities and challenges faced when it came to those deals. He also discuss how he navigated through the due diligence process on those transactions and more.
Tuesday Jun 11, 2024
TechTalk: Alzheimer’s Breakthrough Therapy Emerges from Seed-Stage Startup
Tuesday Jun 11, 2024
Tuesday Jun 11, 2024
Ken Mariash, CEO of Sinaptica Therapeutics, talks with EisnerAmper's TechTalk host Janina Teoxon about the novel approach his startup is taking to develop a non-drug therapy to treat Alzheimer's. In this episode, Ken acknowledges the repeated failures the industry has faced on its quest to find a cure for the disease and explains why his personalized and connectome-targeted neuromodulation approach has gained the FDA breakthrough designation. Learn how Ken and his team are overcoming investor skepticism as their promising treatment emerges.